Evidence map›Paper›PMID 36619150›Full record

ReviewMiddle East journal of digestive diseases2022

Gut Microbiota Modification via Glucagon-like Peptide-1 with Beneficial Neuroprotective Effects.

Fatemeh Sayehmiri, Mohammad Samadian, Ashraf Mohamadkhani, Abbas Tafakhori, Somayeh Haghighat, Aryoobarzan Rahmatian, Mohammad Ali Mohammadkhani, Hamid Reza Fazli, Mostafa Rezaei Tavirani

Open access · diamondAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Middle East journal of digestive diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Fatemeh SayehmiriStudent Research Committee, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Mohammad SamadianSkull Base Research Center, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Ashraf MohamadkhaniLiver and Pancreatobiliary Diseases Research Center, Digestive Disease Research Institute, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Abbas TafakhoriAssociate Professor of Neurology, Iranian Center of Neurological Science; Tehran University of Medical Sciences; Tehran, Iran.
Somayeh HaghighatPhysiology Research Center, Kashan University of Medical Sciences, Kashan, Iran.
Aryoobarzan RahmatianFaculty of Medicine, Department of neurology, Ilam University of medical science, Ilam, Iran.
Mohammad Ali MohammadkhaniTechnical and Vocational University, Tehran, Iran.
Hamid Reza FazliLiver and Pancreatobiliary Diseases Research Center, Digestive Disease Research Institute, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Mostafa Rezaei TaviraniProteomics Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Shahid Beheshti University of Medical Sciences · IRTehran University of Medical Sciences · IRIlam University · IRKashan University of Medical Sciences · IRTechnical and Vocational University · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Alzheimer diseaseNeurodegenerative diseasesParkinson disease

Identifiers

PMID36619150
PMCPMC9489313
OpenAlexW4290000710

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.